About this trial
The project's aim is to investigate the effect of a transdiagnostic, self-guided, internet-based cognitive behavioral therapy program in waitlist patients with anxiety disorders.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of panic disorder with or without agoraphobia, social anxiety disorder, or generalized anxiety disorder
Knowledge of German that is sufficient for engaging with the treatment and responding to the questionnaires
Written informed consent
Internet access
Disqualifiers
Diagnoses of severe mental comorbidities (e.g., schizophrenia, severe major depression, borderline personality disorder)
Acute suicidality
Started or changed anxiolytic pharmacotherapy recently (currently or in the past four weeks)
Trial design
Single group
Treatments tested in this trial
Velibra
BehavioralVelibra is an internet-based cognitive behavioral therapy program developed by GAIA AG. It consists of six modules which are meant to be completed over a span of 6 weeks. The first module educates participants about anxiety and the treatment program. The second module focuses on cognitive techniques for dealing with anxiety. In the third module, relaxation techniques are practiced. The fourth module encourages the participant to practice non-anxious behaviors. In the fifth module, the central topic is the experience of social situations in non-anxious ways. The sixth and final module consists of a summary and recapitulation of the most important content.
Treatment groups
Trial outcomes
Primary outcomes
Panic and Agoraphobia Scale (PAS)
The Panic and Agoraphobia Scale (PAS) is a self-report questionnaire used to measure the symptom severity of panic disorder with or without agoraphobia. It is given to study participants diagnosed with panic disorder with or without agoraphobia. Total score values range from 0 to 52, with higher scores indicating a worse outcome.
Panic and Agoraphobia Scale (PAS)
The Panic and Agoraphobia Scale (PAS) is a self-report questionnaire used to measure the symptom severity of panic disorder with or without agoraphobia. It is given to study participants diagnosed with panic disorder with or without agoraphobia. Total score values range from 0 to 52, with higher scores indicating a worse outcome.
Panic and Agoraphobia Scale (PAS)
The Panic and Agoraphobia Scale (PAS) is a self-report questionnaire used to measure the symptom severity of panic disorder with or without agoraphobia. It is given to study participants diagnosed with panic disorder with or without agoraphobia. Total score values range from 0 to 52, with higher scores indicating a worse outcome.
Panic and Agoraphobia Scale (PAS)
The Panic and Agoraphobia Scale (PAS) is a self-report questionnaire used to measure the symptom severity of panic disorder with or without agoraphobia. It is given to study participants diagnosed with panic disorder with or without agoraphobia. Total score values range from 0 to 52, with higher scores indicating a worse outcome.
Secondary outcomes
Beck Anxiety Inventory (BAI)
The Beck Anxiety Inventory (BAI) is a self-report questionnaire used to measure the symptom severity of anxiety in general. It is given to all study participants regardless of diagnosis. Total score values range from 0 to 63, with higher scores indicating a worse outcome.
Beck Anxiety Inventory (BAI)
The Beck Anxiety Inventory (BAI) is a self-report questionnaire used to measure the symptom severity of anxiety in general. It is given to all study participants regardless of diagnosis. Total score values range from 0 to 63, with higher scores indicating a worse outcome.
Beck Anxiety Inventory (BAI)
The Beck Anxiety Inventory (BAI) is a self-report questionnaire used to measure the symptom severity of anxiety in general. It is given to all study participants regardless of diagnosis. Total score values range from 0 to 63, with higher scores indicating a worse outcome.
Beck Anxiety Inventory (BAI)
The Beck Anxiety Inventory (BAI) is a self-report questionnaire used to measure the symptom severity of anxiety in general. It is given to all study participants regardless of diagnosis. Total score values range from 0 to 63, with higher scores indicating a worse outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.